↓ Skip to main content

Dove Medical Press

Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy

Overview of attention for article published in Biologics: Targets & Therapy, December 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

twitter
1 X user
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
97 Mendeley
Title
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
Published in
Biologics: Targets & Therapy, December 2018
DOI 10.2147/btt.s114530
Pubmed ID
Authors

Michelle E Keyel, C Patrick Reynolds

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 97 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 13%
Student > Doctoral Student 10 10%
Student > Master 9 9%
Student > Bachelor 9 9%
Researcher 7 7%
Other 15 15%
Unknown 34 35%
Readers by discipline Count As %
Medicine and Dentistry 21 22%
Biochemistry, Genetics and Molecular Biology 12 12%
Agricultural and Biological Sciences 10 10%
Immunology and Microbiology 3 3%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 10 10%
Unknown 38 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2022.
All research outputs
#4,838,109
of 25,385,509 outputs
Outputs from Biologics: Targets & Therapy
#57
of 284 outputs
Outputs of similar age
#100,048
of 445,442 outputs
Outputs of similar age from Biologics: Targets & Therapy
#1
of 4 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,442 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them